Falcon Genomics Wins $270K NIH Grant to Develop Breast Cancer Biochip | GenomeWeb

This story has been updated from a previous version to include additional comments from the company.

By Justin Petrone

The National Institutes of Health recently awarded Falcon Genomics a $269,640 grant to help it develop a biochip-based test that will be used for both cancer target identification and diagnostics.

Entitled "Development of a Test Cancer Biochip for the Cancer Biochip System," the one-year grant started Sept. 1 and is scheduled to end on Aug. 31, 2011.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

Sponsored by
Agilent Technologies

This online seminar will discuss a metagenomic assay to identify viruses and other pathogenic microorganisms in human tumor samples, with the aim of gaining a more comprehensive understanding of the role of the microbiome in cancer development and treatment.